Historical record - last NADAC publication: 4/9/2014
Product Information
TEMOZOLOMIDE 180 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $313.4079 per EA under NDC 47335093080. Its NADAC has been published 45 times since Apr 9, 2014.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335093080
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/9/2014
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 180 MG CAPSULE has been published 45 times since Apr 9, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $313.4079 per EA |
|---|---|
| All-time high | $313.4079 (Feb 11, 2015) |
| All-time low | $313.4079 (Apr 9, 2014) |
| Median price | $313.4079 |
| Average price | $313.4079 |
| Largest weekly change | 0.0% (Apr 16, 2014) |
| Weeks tracked | 45 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 180 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $313.4079 per EA (NDC 47335093080), effective Feb 11, 2015.
How has the price of TEMOZOLOMIDE 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 180 MG CAPSULE?
Since Apr 9, 2014, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has ranged from a low of $313.4079 (Apr 9, 2014) to a high of $313.4079 (Feb 11, 2015), with a median of $313.4079 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 180 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 180 MG CAPSULE, is $21.4132 per EA — about 93% below TEMOZOLOMIDE 180 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 180 MG CAPSULE?
TEMOZOLOMIDE 180 MG CAPSULE (NDC 47335093080) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification